Atmospheric Pressure Chemical Ionization mass spectrometry (APCI-MS) paired with mass trial tags—such as tag 110—provides high-precision structural identification and quantitative profiling for custom research peptides. This analytical methodology allows laboratory investigators to verify molecular weight, confirm sequence fidelity, and track reporter ions at m/z 110 in complex preclinical assays. PX1 Research provides USA-manufactured research compounds validated by rigorous APCI-MS and HPLC testing.
Atmospheric Pressure Chemical Ionization mass spectrometry (APCI-MS) paired with mass trial tags—such as tag 110—provides high-precision structural identification and quantitative profiling for custom research peptides. This analytical methodology allows laboratory investigators to verify molecular weight, confirm sequence fidelity, and track reporter ions at m/z 110 in complex preclinical assays. PX1 Research provides USA-manufactured research compounds validated by rigorous APCI-MS and HPLC testing.
In analytical chemistry and proteomic research, Atmospheric Pressure Chemical Ionization mass spectrometry (APCI-MS) using trial tag 110 reporter ions represents a standardized method for mass determination and quantitative isobaric tagging. A trial tag 110 standard refers to a chemical label or reference tag generating a characteristic reporter fragment ion at m/z 110 during collision-induced dissociation (CID), allowing precise multiplexed tracking and spectral calibration.
Supplied exclusively as a research-grade compound for in vitro and laboratory investigation, tag 110 calibration standards allow researchers to evaluate instrument sensitivity, quantify ionization efficiency, and establish baseline mass accuracy. Integrating these standards into laboratory workflows ensures that synthetic research peptides maintain structural integrity prior to experimental deployment.
APCI is a soft ionization technique operating at atmospheric pressure, utilizing gas-phase ion-molecule reactions to ionize analytes. Unlike Electrospray Ionization (ESI), which ionizes species directly from liquid droplets, APCI employs a heated vaporizer tube to desolvate the analyte solution before subjecting the vaporized solvent and sample to a high-voltage corona discharge needle.
The corona discharge ionizes primary solvent molecules (such as acetonitrile, methanol, or water), forming primary reagent ions. These reagent ions subsequently transfer charge to the target analyte via proton transfer, charge exchange, or adduct formation. In preclinical mass spectrometry experiments, APCI proves exceptionally effective for non-polar, moderately polar, and thermally stable low-to-medium molecular weight compounds where ESI ion suppression might otherwise impair detection limits.
Mass tags—including trial tag 110 variants—are synthetic labels engineered with three distinct functional domains: an amine-reactive or thiol-reactive targeting group, a mass balance region, and a reporter group. In tandem mass spectrometry (MS/MS) modes, energy imparted during high-energy collisional dissociation (HCD) cleaves the mass balance group, releasing the low-mass reporter ion at m/z 110.1.
The m/z 110 reporter ion signature provides a distinct mass peak free from background interference in lower mass spectra ranges. Researchers utilize tag 110 standards to establish baseline response factors across multiplexed samples, allowing quantitative comparison of target peptides across different experimental groups in robust in vitro research models.
Preclinical literature demonstrates that APCI mass spec and trial tag 110 workflows are critical across several analytical disciplines, including peptide degradation kinetics, pharmacokinetic modeling in animal tissue lysates, and structural confirmation of synthetic peptides. In vitro data indicate that utilizing calibrated trial tags improves signal-to-noise ratios when monitoring trace peptide metabolites.
For instance, when evaluating candidate signaling peptides such as BPC 157 5mg or structural compounds like TB-500 10mg, baseline characterization via MS/MS fragmentation ensures that the primary sequence remains intact without degradation products. Researchers rely on tag 110 calibration to confirm that mass spectrometers maintain sub-ppm mass accuracy across extended analytical runs.
To achieve optimal chromatographic resolution prior to MS detection, liquid chromatography is seamlessly coupled with APCI mass spectrometry. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) using C18 or C8 stationary phases serves as the primary separation mode, utilizing water and acetonitrile mobile phases modified with 0.1% formic acid or trifluoroacetic acid (TFA).
The eluted compounds enter the APCI source, where vaporizer temperatures typically set between 350°C and 450°C ensure rapid desolvation. Maintaining precise temperature control prevents thermal degradation of labile peptide bonds while facilitating complete gas-phase ionization. Researchers interested in method development can consult our comprehensive guide on HPLC purity verification for detailed mobile phase optimization parameters.
Full-scan MS spectra generated via APCI provide primary [M+H]+ or [M-H]- parent ion information, confirming the nominal molecular weight of the tagged analyte. Subsequent MS/MS fragmentation provides structural fingerprints by cleaving peptide backbone bonds to generate characteristic b-ion and y-ion series alongside the trial tag 110 reporter fragment.
This dual-stage verification confirms both identity and purity simultaneously. When evaluating complex multi-peptide assays, researchers often compare fragmentation patterns against reference libraries to detect trace contaminants, amino acid substitutions, or incomplete synthesis sequences prior to initiating secondary biological screening.
When designing analytical protocols for structural verification, researchers must select the optimal ionization source and tagging chemistry based on analyte polarity and molecular weight. While Electrospray Ionization (ESI-MS) remains standard for large biomacromolecules, APCI-MS offers distinct advantages for smaller, less polar, or heavily derivatized research peptides.
In direct analytical comparisons, APCI demonstrates lower susceptibility to matrix suppression caused by salts or detergents compared to ESI. When evaluating tagged research compounds—such as comparing CJC-1295 No DAC, Ipamorelin 5mg, and GHRP-6 5mg—APCI-MS provides clean singly-charged pseudo-molecular ions ([M+H]+), whereas ESI frequently generates multiply-charged species ([M+2H]2+, [M+3H]3+) that require complex charge-deconvolution algorithms. Integrating trial tag 110 standards across both ion source modes allows laboratories to cross-calibrate signal intensities and validate absolute quantification parameters.
At PX1 Research, quality verification is embedded into every stage of manufacturing. All research compounds undergo rigorous analytical validation in GMP-compliant, ISO 17025 certified facilities within the United States. We verify raw material purity, molecular structure, and lot uniformity prior to distribution.
Every product batch is accompanied by a public, lot-specific Certificate of Analysis (COA) detailing identity confirmation via mass spectrometry (ESI-MS or APCI-MS) and purity verification via RP-HPLC showing >98% purity. Furthermore, all compounds undergo chromogenic LAL testing to ensure endotoxin levels remain strictly below <0.01 EU/mg, protecting the integrity of sensitive cell culture and in vitro experimental models.
To preserve the chemical stability of research peptides and analytical mass tags, proper laboratory handling is essential. Lyophilized peptides and tag 110 standards should be stored upon receipt at -20°C or -80°C in a desiccated environment to prevent moisture absorption and hydrolytic degradation.
When preparing samples for HPLC/APCI-MS analysis, reconstitute lyophilized vials using LC-MS grade solvents, such as sterile mass-spectrometry grade water or acetonitrile with 0.1% formic acid. Allow frozen vials to acclimate to room temperature prior to opening to minimize condensation inside the container. For detailed step-by-step reconstitution ratios and solvent compatibility charts, review our technical peptide reconstitution guide.
Selecting a reliable supplier for analytical standards and research-grade peptides is critical to generating reproducible scientific data. PX1 Research stands as a premier USA-based supplier, operating state-of-the-art facilities located in California and Arizona. We offer same-day shipping on orders placed Monday through Friday before cut-off times, ensuring your laboratory receives fresh, un-degraded reagents promptly.
Whether your research group requires single-vial analytical standards or bulk quantities for high-throughput screening, PX1 provides transparent lot traceability, full COA availability, and dedicated customer support. Institutional buyers and academic laboratories can explore volume pricing and supply agreements through our wholesale portal.
What is the primary role of trial tag 110 in APCI mass spec analysis?
Trial tag 110 acts as an isobaric mass reporter tag standard generating a distinct m/z 110.1 ion fragment upon MS/MS collision-induced dissociation. It enables quantitative calibration, signal tracking, and internal reference positioning in mass spectrometry assays.
How does APCI differ from ESI when analyzing research peptides?
APCI relies on gas-phase thermal desolvation and corona discharge ion-molecule reactions, making it ideal for non-polar to moderately polar compounds with lower susceptibility to ion suppression. ESI ionizes directly from liquid droplets, making it preferable for high-molecular-weight polar macromolecules.
Are PX1 Research compounds suitable for human clinical use?
No. All compounds supplied by PX1 Research are strictly intended for laboratory research use only (RUO) and in vitro experimentation. They are never for human or veterinary use, injection, diagnosis, or therapeutic application.
How does PX1 verify the purity of its analytical research compounds?
PX1 Research subjects every product lot to independent third-party testing at ISO 17025 accredited laboratories. Purity is quantified using RP-HPLC (requiring >98% purity), while identity is confirmed via high-resolution ESI-MS or APCI-MS mass spectrometry.
What are the endotoxin limits for PX1 research peptides?
PX1 enforces strict quality thresholds, validating that endotoxin content is tested via Kinetic Chromogenic LAL assays to ensure levels remain below <0.01 EU/mg, minimizing background interference in cell-based research.
What solvent should be used to reconstitute analytical tag standards for MS?
Reconstitution should be performed using LC-MS grade solvents such as 0.1% formic acid in MS-grade water or LC-MS grade acetonitrile, depending on the solubility profile of the specific peptide tag compound.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in GMP-compliant facilities in the USA and shipped directly from our primary distribution centers located in California and Arizona.
How should reconstituted mass spectrometry standards be stored?
Reconstituted liquid aliquots should be stored at -80°C to prevent freeze-thaw cycles and chemical hydrolysis. Avoid repeated freeze-thaw cycles by dividing stock solutions into single-use experimental volumes.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.